2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 31634796 | Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand. | 2020 May | 2 |
| 2 | 29587666 | Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspective. | 2018 Mar 27 | 1 |